186 related articles for article (PubMed ID: 17332673)
1. Lipid peroxidation, isoprostanes and vascular damage.
Minuz P; Fava C; Lechi A
Pharmacol Rep; 2006; 58 Suppl():57-68. PubMed ID: 17332673
[TBL] [Abstract][Full Text] [Related]
2. Isoprostanes and other markers of peroxidation in atherosclerosis.
Patrignani P; Tacconelli S
Biomarkers; 2005 Nov; 10 Suppl 1():S24-9. PubMed ID: 16298908
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
Proudfoot J; Barden A; Mori TA; Burke V; Croft KD; Beilin LJ; Puddey IB
Anal Biochem; 1999 Aug; 272(2):209-15. PubMed ID: 10415090
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
Musiek ES; Yin H; Milne GL; Morrow JD
Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
[TBL] [Abstract][Full Text] [Related]
5. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.
Lim PS; Chang YM; Thien LM; Wang NP; Yang CC; Chen TT; Hsu WM
Blood Purif; 2002; 20(6):537-42. PubMed ID: 12566669
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
Mezzetti A; Cipollone F; Cuccurullo F
Cardiovasc Res; 2000 Aug; 47(3):475-88. PubMed ID: 10963721
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation in obese women: role of inflammation and oxidant stress.
Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
[TBL] [Abstract][Full Text] [Related]
8. In vivo lipid peroxidation and platelet activation in cystic fibrosis.
Ciabattoni G; Davì G; Collura M; Iapichino L; Pardo F; Ganci A; Romagnoli R; Maclouf J; Patrono C
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1195-201. PubMed ID: 11029317
[TBL] [Abstract][Full Text] [Related]
9. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
Cracowski JL; Durand T; Bessard G
Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
[TBL] [Abstract][Full Text] [Related]
10. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
[TBL] [Abstract][Full Text] [Related]
11. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.
Song WL; Paschos G; Fries S; Reilly MP; Yu Y; Rokach J; Chang CT; Patel P; Lawson JA; Fitzgerald GA
J Biol Chem; 2009 Aug; 284(35):23636-43. PubMed ID: 19520854
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
[TBL] [Abstract][Full Text] [Related]
13. Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF(2α)/PGF(2α) ratio distinguishes chemical from enzymatic lipid peroxidation.
van 't Erve TJ; Lih FB; Kadiiska MB; Deterding LJ; Eling TE; Mason RP
Free Radic Biol Med; 2015 Jun; 83():245-51. PubMed ID: 25772010
[TBL] [Abstract][Full Text] [Related]
14. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
Minuz P; Patrignani P; Gaino S; Degan M; Menapace L; Tommasoli R; Seta F; Capone ML; Tacconelli S; Palatresi S; Bencini C; Del Vecchio C; Mansueto G; Arosio E; Santonastaso CL; Lechi A; Morganti A; Patrono C
Circulation; 2002 Nov; 106(22):2800-5. PubMed ID: 12451006
[TBL] [Abstract][Full Text] [Related]
15. Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis.
Santilli F; Vazzana N; Iodice P; Lattanzio S; Liani R; Bellomo RG; Lessiani G; Perego F; Saggini R; Davì G
Thromb Haemost; 2013 Dec; 110(6):1232-40. PubMed ID: 24030807
[TBL] [Abstract][Full Text] [Related]
16. Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation.
Tacconelli S; Capone ML; Patrignani P
Methods Mol Biol; 2010; 644():165-78. PubMed ID: 20645173
[TBL] [Abstract][Full Text] [Related]
17. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.
Greco A; Minghetti L
Curr Neurovasc Res; 2004 Oct; 1(4):341-54. PubMed ID: 16181083
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats.
Södergren E; Cederberg J; Basu S; Vessby B
J Nutr; 2000 Jan; 130(1):10-4. PubMed ID: 10613758
[TBL] [Abstract][Full Text] [Related]
19. The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis.
Miller E; Mrowicka M; Saluk-Juszczak J; Ireneusz M
Neurochem Res; 2011 Jun; 36(6):1012-6. PubMed ID: 21399906
[TBL] [Abstract][Full Text] [Related]
20. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo.
Praticò D
Atherosclerosis; 1999 Nov; 147(1):1-10. PubMed ID: 10525118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
